Regeneron Pharmaceuticals, Inc. (REGN)
726.35
+33.77
(+4.88%)
USD |
NASDAQ |
Dec 10, 16:00
727.00
+0.65
(+0.09%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap: 76.34B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.78B |
| Johnson & Johnson | 497.54B |
| Eli Lilly & Co. | 888.93B |
| Merck & Co., Inc. | 242.20B |
| Pfizer Inc. | 146.55B |
Market Cap Related Metrics
| PE Ratio | 17.39 |
| PS Ratio | 5.618 |
| PEG Ratio | 5.171 |
| Price to Book Value | 2.466 |
| Price to Free Cash Flow | 20.62 |
| Price | 726.35 |
| Earnings Yield | 5.75% |
| PEGY Ratio | 5.171 |
| Operating PE Ratio | 20.90 |
| Normalized PE Ratio | 18.10 |